SMP0126310
View Pathway
|
Clevidipine Action Pathway
Homo sapiens
Matched Description: oral antihypertensive therapy is not feasible or not desirable. Clevidipine is used IV only and … myocardial, smooth muscle and, therefore, has little or no effect on myocardial contractility or … , and without reducing central venous pressure or reducing cardiac output. Possibly by deforming the … channel, inhibiting ion-control gating mechanisms, and/or interfering with the release of calcium … the myocardial and vascular smooth muscle cell membranes. Some side effects of using clevidipine
|
SMP0125867
View Pathway
|
Hydroxychloroquine Action Pathway
Plasmodium falciparum
Matched Description: Hydroxychloroquine is an antimalarial medication used to treat uncomplicated cases of malaria and … ) indicated for treatment of rheumatoid arthritis and lupus erythematosus. Hydroxychloroquine is an … hydroxychloroquine and chloroquine in the treatment of COVID-19 was revoked on 15 June 2020.
The exact … parasite's ability to proteolyse hemoglobin, preventing the normal growth and replication of the … autoimmue diseases and interferes with the ability of plasmodia to proteolyse hemoglobin for their
|
SMP0126656
View Pathway
|
Tioguanine Action Pathway
Homo sapiens
Matched Description: antimetabolite action. Tioguanine is indicated for remission induction and remission consolidation in the … hypoxanthine and guanine for the hypoxanthine-guanine phosphoribosyltransferase (HGPRTase) and is itself … . Thioguanine nucleotides are incorporated into both the DNA and the RNA. The final result is the sequential … blockade of the usage and synthesis of purines, leading to apoptosis in the S phase of the cell cycle … nausea, vomiting, malaise, hypotension, and diaphoresis.
|
SMP0126973
View Pathway
|
Muscular Gi Protein Cascade
Mus musculus
Matched Description: molecular switches inside cells, and are involved in transmitting signals from a variety of stimuli … to bind to and hydrolyze guanosine triphosphate (GTP) to guanosine diphosphate (GDP). When they are … bound to GTP, they are 'on', and, when they are bound to GDP, they are 'off'. G proteins belong to … to a domain of the GPCR located outside the cell, and an intracellular GPCR domain then in turn … protein-coupled receptors and G proteins working together transmit signals from many hormones
|
SMP0126621
View Pathway
|
Tacrine Action Pathway (new)
Homo sapiens
Matched Description: also counters the effects of muscle relaxants, respiratory stimulants and other central nervous … disorders. Its mechanism of action is not fully known but is thought that the drug reversibly binds and … inhibits cholinesterase and acetylcholinesterase. Stopping the breakdown of acetylcholine leads to … cholinergic receptors being further stimulated and accumulating in the synaptic cleft. Tacrine is a … of mild to moderate dementia as seen in Alzheimer's. Symptoms of memory loss and deficiencies in
|
SMP0126628
View Pathway
|
Busulfan Action Pathway
Homo sapiens
Matched Description: before bone marrow transplantation for acute myeloid leukemia and nonmalignant disease. This drug is cell … cycle-nonspecific and works by three different mechanisms. Those all lead to the disruption of the … DNA and the apoptosis of the cell. Busulfan contains two labile methanesulfonate groups. After the … hydrolyzation of the molecule, the methanesulfonate groups are released and carbonium ions are … replication and RNA transcription. Specifically, busulfan creates intrastrand crosslinks between
|
SMP0125223
View Pathway
|
Benzylpenicillin Action Pathway (New)
Staphylococcus aureus (strain USA300)
Matched Description: microorganisms when rapid and high penicillin levels are required such as in the treatment of … septicemia, meningitis, pericarditis, endocarditis and severe pneumonia.
Penicillin G inhibits penicillin … binding proteins. Penicillin binding proteins are responsible for glycosyltransferase and … transpeptidase reactions that lead to cross-linking of D-alanine and D-aspartic acid in bacterial cell walls … . Inhibition of this protein leads to upregulation of autolytic enzymes and inhibition of cell wall
|
SMP0125018
View Pathway
|
Morphine Opioid Agonist Action Pathway
Homo sapiens
Matched Description: Morphine is an opioid agonist used for the relief of moderate to severe acute and chronic pain … complex. As the effector system is adenylate cyclase and cAMP located at the inner surface of the … -operated calcium channels and open calcium-dependent inwardly rectifying potassium channels. This … results in hyperpolarization and reduced neuronal excitability. Morphine acts at A delta and C pain … and kappa opioid receptors in the nucleus accumbens where the reward pathway is activated.
|
SMP0126208
View Pathway
|
Metipranolol Action Pathway (New)
Homo sapiens
Matched Description: effective for both beta-1 and beta-2 receptors. It is used as an antiarrhythmic, antihypertensive, and … antiglaucoma agent. Metipranolol is a beta1 and beta2 (non-selective) adrenergic receptor-blocking agent … the pathogenesis of glaucomatous visual field loss and optic nerve damage. Metipranolol reduces … blocking agents reduce aqueous humor production, as demonstrated by tonography and fluorophotometry. A … metipranolol may include changes in vision, difficulty breathing, irregular heartbeat, and bloody nose.
|
SMP0401757
View Pathway
|
Lipopolysaccharide Biosynthesis
Bacteroides clarus YIT 12056
Matched Description: either the fructose 6-phosphate produced by glycolysis and pyruvate dehydrogenase or obtained from the … and a glucosamine 6-phosphate. The latter compound is isomerized through a phosphoglucosamine mutase … through a bifunctional protein glmU resulting in a Coenzyme A, hydrogen ion and N-acetyl-glucosamine 1 … -phosphate. The latter interacts with UTP and hydrogen ion through the bifunctional protein glmU … resulting in a pyrophosphate and a UDP-N-acetylglucosamine. UDP-N-acetylglucosamine iinteracts with (3R)-3
|